Whitelogolarge.jpg
SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – CHS, ICPT, ORTX, SRT
October 18, 2023 17:35 ET | Monteverde & Associates PC
NEW YORK, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Whitelogolarge.jpg
ALERT: The M&A Class Action Firm Continues Investigating the Merger – ICPT, SPLK, RPT, PFSW
September 27, 2023 20:35 ET | Monteverde & Associates PC
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
LOGO.jpg
ICPT FINAL DEADLINE MONDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPT
January 01, 2021 19:15 ET | The Rosen Law Firm PA
NEW YORK, Jan. 01, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...
LOGO.jpg
ROSEN, A TOP RANKED LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action – ICPT
December 24, 2020 15:56 ET | The Rosen Law Firm PA
NEW YORK, Dec. 24, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for HPQ, ICPT, and NVCN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
December 22, 2020 11:30 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
LOGO.jpg
ROSEN, A GLOBAL AND LEADING LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action – ICPT
December 10, 2020 17:28 ET | The Rosen Law Firm PA
NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for HPQ, ICPT, and NVCN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
December 10, 2020 11:15 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
Zahng-Investor-Law.png
ICPT STOCK DEADLINE: Zhang Investor Law Reminds Investors with Losses of the Deadline in Securities Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. – ICPT
December 08, 2020 14:00 ET | Zhang Investor Law P.C.
NEW YORK, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for HPQ, ICPT, and NVCN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
December 04, 2020 11:15 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 04, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
LOGO.jpg
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – ICPT
December 03, 2020 19:45 ET | The Rosen Law Firm PA
NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...